Blog

Cybersecurity has become an essential consideration for medtech. I discussed the basics in my last blog, where I expanded on how...

Interoperability is a capability that’s been discussed for some time but, until now, a lack of precision in the way the term is used...

Digital Therapeutics (DTx) is among the most promising avenues for digital health at present: in fact, just last month, Reuters quoted...

In digital health, healthcare professionals (HCPs) are often gatekeepers for patient adoption. HCPs can make or break a solution by...

As the digital health industry has grown, so has the complexity of digital health tools and the range of tasks they can fulfill.

This year’s Frontiers Health Global Conference is just a few weeks away, where thought leaders, policy makers, industry stakeholders,...

There’s a myriad of digital health terms out there, all of them meaning different things to different people. In some cases, even...

2021 has been a challenging year for pharma.

Digital health offers many exciting opportunities for pharma, but it’s important to invest in the correct type of solution to deliver...

Low-level, low-impact digital solutions, like those that focus solely on patient education, onboarding, or initial engagement, no...

DUBLIN, Ireland and CHICAGO – May 26, 2021 – EVERSANA™, the pioneer of next generation commercial services to the global life sciences...

At such a pivotal time for digital health, it’s imperative that healthcare organizations take the necessary steps to ensure the...

The events of 2020 have demonstrated clearly just how vital connectivity is to healthcare.

Just like that, Frontiers Health 2020 is over.

There's just days to go until Frontiers Health 2020. If you’re anything like the team here at S3 Connected Health, you’ll have been...

Though the new European Union Medical Device Regulation (MDR) is set to fully apply from May 2021, there’s still uncertainty around...

The United Kingdom is an attractive market for any digital therapeutics (DTx) or digital health company. The UK National Health...

The medical world is undergoing a digital revolution. The global digital health sector saw its best first quarter since analysts began...

Pharma companies are under constant pressure to innovate and stay competitive, whether that’s in drug discovery, business strategy, or...

Pharma’s approach to digital health is maturing fast. Companies are now investing more in digital health solutions designed to deliver...

Pharma companies have long been using data, whether it’s to accelerate drug discovery and development, or improve clinical trials.

Whether it’s teething problems in the past with systems like electronic health records, or confusion around the myriad of different...

What happens when your sole method of qualitative research is taken away from you? Traditionally conducted face-to-face, qualitative...

Digital health solutions and digital therapeutics are rapidly becoming a vital component of the pharmaceutical industry’s ability to...

The benefits of a well-executed, digitized health service are numerous: improving patient outcomes, reducing healthcare costs, and...

FREE WEBINAR | January 30th, 2020 | 2pm London / 3pm Paris / 9am NY

As this year’s crop of ‘2020 trends for pharma’ articles flood our inboxes, it seems that digital therapeutics (DTx) is popping up...

‘If any digital health solution is to have an impact, adoption by its intended end users is critical. Securing adoption might sound...

We are in the midst of a seismic shift in healthcare. The need to drive down costs, coupled with new ways of using data and technology...

S3 Connected Health and FutureNeuro, the Science Foundation Ireland (SFI) Research Center for chronic and rare neurological diseases...

Article published by Jim O’Donoghue, President of S3 Connected Health on PharmaTimes on 8 May 2019.

Article published by Jim O’Donoghue, President of S3 Connected Health on PharmaPhorum on 1 April 2019.

Article published by Sean Gill, Principal Behavioral Scientist, S3 Connected Health on PharmaPhorum on 22 January 2019.

Article published by Jim O’Donoghue, President, S3 Connected Health on PharmaTimes on 2 January 2019.

Article published by Jim O’Donoghue, President, S3 Connected Health on PharmExec on 9 January 2019.

To a clinician, health care provider or even a care giver the appropriate response and actions needed in response to a Type II...

16 October 2018

Published on Eyeforpharma Social on 15th October 2018

Published in PharmExec on 20th September 2018

Published in PharmaTimes on 29th June 2018

Self-management has the potential to improve the lives of patients living with chronic conditions dramatically. However, to...

Survey of pharma leaders finds widespread view that patient support programs hold huge value and potential as future revenue stream...

Published in PharmExec on 16th April 2018

Patients’ expectations about engaging with their treatment and care are changing. Not only do patients expect improved healthcare...

The terms activation and engagement are often used synonymously. However, if patient support services are to truly enable patients to...

There are a broad range of services, supports and initiatives that operate under the term Patient Engagement. While partly a result of...

Patient Engagement is a broad term and is used to describe a wide range of initiatives. A quick search of the term results in MCM...